Cours Innovus Pharmaceuticals Inc OTC Bulletin Board
Actions
US45778V1061
Produits pharmaceutiques
Cours en clôture
Autres places de cotation
|
||
- USD | - |
|
Dirigeants | Titre | Age | Depuis |
---|---|---|---|
Joshua Disbrow
CEO | Chief Executive Officer | 49 | - |
Chief Operating Officer | - | 01/06/18 | |
Steven Klayman
PRN | Corporate Officer/Principal | - | - |
Varia. 1 janv. | Capi. | |
---|---|---|
+51,82% | 791 Md | |
+40,45% | 630 Md | |
+16,95% | 328 Md | |
+9,49% | 298 Md | |
+17,25% | 246 Md | |
+0,41% | 225 Md | |
+10,22% | 218 Md | |
+5,30% | 160 Md | |
-6,29% | 156 Md |